• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 6-K filed by iTonic Holdings Ltd

    1/26/26 8:00:16 AM ET
    $ITOC
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care
    Get the next $ITOC alert in real time by email
    6-K 1 ea0274042-6k_itonic.htm REPORT OF FOREIGN PRIVATE ISSUER

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 6-K

     

    REPORT OF FOREIGN PRIVATE ISSUER
    PURSUANT TO RULE 13a-16 OR 15d-16
    UNDER THE SECURITIES EXCHANGE ACT OF 1934

     

    For the month of January 26, 2026

     

    Commission File Number: 001-42263

     

    iTonic Holdings Ltd

     

    Room 306, NET Building

    Hong Jun Ying South Road, Chaoyang District

    Beijing, China

     

    Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

     

    Form 20-F ☒           Form 40-F ☐

     

     

     

     

     

     

    Resignation of Yun Fai Wong as independent director

     

    On January 22, 2026, Mr. Yun Fai Wong tendered to iTonic Holdings Ltd (the “Company”) his resignation as an independent director of the Company, effectively immediately.

     

    Mr. Wong’s resignation was due to personal reasons, and not as a result of any disagreement between Mr. Wong and the Company on any matter relating to the Company’s operations, policies or practices.

     

    Appointment of Bin Wu as independent director

     

    Concurrently with the resignation of Mr. Wong, the board of directors of the Company appointed Mr. Bin Wu to succeed Mr. Wong as a new independent director of the Company on January 22, 2026. Mr. Wu was also appointed to succeed Mr. Wong as a member of the Audit Committee, the Corporate Governance and Nominating Committee and the Compensation Committee of the Company and will replace Mr. Yun Fai Wong as the chair of the Corporate Governance and Nominating Committee. Mr. Bin Wu will become the new chair of the Corporate Governance and Nominating Committee. Mr. Wu graduated from Wuhan University in July 1987 and obtained a Master of Business Administration from Duke University.

     

    The Company believes that Mr. Bin Wu qualifies as an independent director of the Company in accordance with Nasdaq Listing Rules and regulations of the Securities and Exchange Commission.

     

    In connection with Mr. Wu’s appointment, the Company has entered into a director agreement and an indemnification agreement with Mr. Wu.

     

    1

     

     

    Exhibits

     

    Exhibit No.   Description
    4.1   Form of Director Agreement, entered by and between Mr. Wu and the Company.
    4.2   Form of Indemnification Agreement, entered by and between Mr. Wu and the Company

     

    2

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

     

      iTonic Holdings Ltd
         
    Date: January 26, 2026 By: /s/ Jianfei Zhang
      Name:  Jianfei Zhang
      Title: Chief Executive Officer and
    Chairman of the Board of Directors

     

     

    3

     

    Get the next $ITOC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ITOC

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $ITOC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Zhang Pengfei

    3 - iTonic Holdings Ltd (0001970544) (Issuer)

    3/16/26 9:50:43 PM ET
    $ITOC
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form 3 filed by new insider Li Zhixin

    3 - iTonic Holdings Ltd (0001970544) (Issuer)

    3/16/26 4:54:48 PM ET
    $ITOC
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $ITOC
    SEC Filings

    View All

    SEC Form EFFECT filed by iTonic Holdings Ltd

    EFFECT - iTonic Holdings Ltd (0001970544) (Filer)

    2/24/26 12:15:07 AM ET
    $ITOC
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form 6-K filed by iTonic Holdings Ltd

    6-K - iTonic Holdings Ltd (0001970544) (Filer)

    1/26/26 8:00:16 AM ET
    $ITOC
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care